|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Somatic Mutations of APC Presenting Polymorphisms in the Hamartomatous Polyps of the Colon
Jin Cheon Kim, Seon Ae Roh, Hee Cheol Kim, Chang Sik Yu, Nichoias E Beck, Walter F Bodmer
J Korean Cancer Assoc.
1999;31(6):1288-1296.
Treatment of Hepatic Metastasis of Colorectal Cancer: A Retrospective Analysis of the Outcome in 99 Patients
Jin Cheon Kim, Chang Nam Kim, Chang Sik Yu, Han Il Lee, Sang We Kim, Je Hwan Lee, Woo Kun Kim, Gyeong Hoon Kang, Moon Kyu Lee
J Korean Cancer Assoc.
1998;30(6):1175-1183.
Multiple Primary Malignant Neoplasm with Colorectal Cancer
Hee Chul Kim, Chang Nam Kim, Chun Sik Jung, Chang Sik Yu, Jin Cheon Kim
J Korean Cancer Assoc.
1998;30(4):668-674.
Primary Signet Ring Cell Carcinoma of the Colon and Rectum
Hee Chul Kim, Chang Nam Kim, Choon Sik Jeong, Chang Sik Yu, Byung Sik Kim, Hun Kyung Lee, Jin Cheon Kim
J Korean Cancer Assoc.
1998;30(3):521-526.
Microvessel Count and Overexpression of p53 in Early Colorectal Cancer
Young Min Kim, Gyeong Hoon Kang, Suk Kyun Yang, Chang Sik Yu, Jin Cheon Kim
J Korean Cancer Assoc.
1998;30(1):80-88.
A Case of the Pancreatic Pseudocyst due to Metastatic Malignant Melanoma
Bong Soo Chung, Jin Cheon Kim, Chang Sik Yu, Han Il Lee, Chang Nam Kim, Duck Jong Han, Gyeong Hoon Kang
J Korean Cancer Assoc.
1997;29(3):528-533.
Hepatic Intraarterial Chemotherapy in Unresectable Hepatic Metastases of Colorectal Cancer
Jin Cheon Kim, Han Il Lee, Chang Sik Yu, Hee Won Chung, Sang Wee Kim, Jeong Sin Lee, Kun Choon Park
J Korean Cancer Assoc.
1997;29(2):227-234.
1
Journal Impact Factor 4.1